Ye Wang

2.4k total citations
110 papers, 1.4k citations indexed

About

Ye Wang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ye Wang has authored 110 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Pulmonary and Respiratory Medicine, 52 papers in Oncology and 22 papers in Molecular Biology. Recurrent topics in Ye Wang's work include Renal cell carcinoma treatment (15 papers), Ferroptosis and cancer prognosis (13 papers) and Colorectal Cancer Surgical Treatments (8 papers). Ye Wang is often cited by papers focused on Renal cell carcinoma treatment (15 papers), Ferroptosis and cancer prognosis (13 papers) and Colorectal Cancer Surgical Treatments (8 papers). Ye Wang collaborates with scholars based in China, United States and South Korea. Ye Wang's co-authors include Steven L. Chang, Benjamin I. Chung, Jeffrey J. Leow, Shufeng Li, Deok Hyun Han, Jae Heon Kim, Yash S. Khandwala, In Gab Jeong, Mark A. Preston and Quoc‐Dien Trinh and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ye Wang

100 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ye Wang China 19 626 452 410 400 220 110 1.4k
Dharam Kaushik United States 22 543 0.9× 312 0.7× 587 1.4× 507 1.3× 157 0.7× 95 1.5k
Constance Thibault France 20 566 0.9× 586 1.3× 294 0.7× 266 0.7× 232 1.1× 98 1.2k
Muneer J. Al‐Husseini Egypt 15 395 0.6× 629 1.4× 333 0.8× 297 0.7× 234 1.1× 38 1.3k
Maria Tolia Greece 20 389 0.6× 487 1.1× 253 0.6× 281 0.7× 206 0.9× 135 1.3k
Sandeep Padala United States 10 687 1.1× 532 1.2× 539 1.3× 658 1.6× 263 1.2× 40 1.8k
Hans‐Stefan Hofmann Germany 24 913 1.5× 412 0.9× 565 1.4× 674 1.7× 258 1.2× 137 2.2k
Yuichiro Takeda Japan 20 629 1.0× 780 1.7× 351 0.9× 387 1.0× 118 0.5× 123 1.6k
Takahiro Yoneyama Japan 24 665 1.1× 359 0.8× 870 2.1× 380 0.9× 108 0.5× 181 2.1k
Ken Shimada Japan 22 437 0.7× 694 1.5× 312 0.8× 260 0.7× 147 0.7× 104 1.3k
Jie Su Canada 22 241 0.4× 503 1.1× 384 0.9× 300 0.8× 195 0.9× 102 1.4k

Countries citing papers authored by Ye Wang

Since Specialization
Citations

This map shows the geographic impact of Ye Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Wang more than expected).

Fields of papers citing papers by Ye Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Wang. The network helps show where Ye Wang may publish in the future.

Co-authorship network of co-authors of Ye Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ye Wang. A scholar is included among the top collaborators of Ye Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Wang. Ye Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yanchao, Jiayuan Chen, Ye Wang, et al.. (2025). Tumor-homing exosomes enable targeted delivery of siRNA and isoimperatorin for overcoming BTK inhibitor resistance in DLBCL. Materials Today Bio. 35. 102267–102267. 1 indexed citations
3.
Chen, Xuan, et al.. (2024). Interventions strategies and their efficacy in illness perceptions in patients with cancer: A systematic review and meta-analysis. European Journal of Oncology Nursing. 70. 102599–102599. 4 indexed citations
4.
Rao, Wei, Ye Wang, Bei Zhang, et al.. (2024). Clinical value of [18F]AlF-NOTA-FAPI-04 PET/CT for assessing early-stage liver fibrosis in adult liver transplantation recipients compared with chronic HBV patients. Japanese Journal of Radiology. 42(5). 536–545. 7 indexed citations
5.
Wang, Ye, et al.. (2024). A feasibility study of a couple-based illness perception intervention for couples coping with colorectal cancer. European Journal of Oncology Nursing. 73. 102723–102723.
7.
Zhang, Weiwei, Ye Wang, Rui Chen, et al.. (2023). Efficacy comparisons of solvent-based paclitaxel, liposomal paclitaxel, nanoparticle albumin-bound paclitaxel, and docetaxel after neoadjuvant systemic treatment in breast cancer. Nanomedicine Nanotechnology Biology and Medicine. 54. 102707–102707. 5 indexed citations
8.
Li, Qian, Ye Wang, Jiawei Wang, et al.. (2023). Preserving or peeling the inferior mesenteric arterial sheath during laparoscopic rectal cancer surgery: a prospective study of surgical outcomes. BMC Surgery. 23(1). 176–176. 1 indexed citations
9.
Zhu, Xueying, et al.. (2023). Efficacy of perampanel in pediatric epilepsy with known and presumed genetic etiology. Annals of Clinical and Translational Neurology. 10(8). 1374–1382. 4 indexed citations
10.
11.
Wang, Qiubo, Zhenxing Xu, Zhimiao Wang, et al.. (2023). Causality of anti-Helicobacter pylori IgG levels on myocardial infarction and potential pathogenesis: a Mendelian randomization study. Frontiers in Microbiology. 14. 1259579–1259579. 6 indexed citations
12.
Wang, Yushan, Ruihong Wang, Cuiping Ma, et al.. (2023). Identification of pivotal genes with prognostic evaluation value in lung adenocarcinoma by bioinformatics analysis. Cellular and Molecular Biology. 69(8). 221–225. 1 indexed citations
14.
Stasko, Nathan, Adam S. Cockrell, Jacob Kocher, et al.. (2022). A randomized, controlled, feasibility study of RD‐X19 in subjects with mild‐to‐moderate COVID‐19 in the outpatient setting. Clinical and Translational Science. 15(5). 1291–1303. 4 indexed citations
15.
Fan, Wei, Li Niu, Xueying Shi, et al.. (2022). Indolent T-cell lymphoproliferative disorder of gastrointestinal tract with unusual clinical courses: report of 6 cases and literature review. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 482(4). 729–743. 4 indexed citations
16.
Khandwala, Yash S., In Gab Jeong, Deok Hyun Han, et al.. (2017). Surgeon preference of surgical approach for partial nephrectomy in patients with baseline chronic kidney disease: a nationwide population-based analysis in the USA. International Urology and Nephrology. 49(11). 1921–1927. 2 indexed citations
17.
Khandwala, Yash S., In Gab Jeong, Jae Heon Kim, et al.. (2017). The incidence of unsuccessful partial nephrectomy within the United States: A nationwide population-based analysis from 2003 to 2015. Urologic Oncology Seminars and Original Investigations. 35(12). 672.e7–672.e13. 14 indexed citations
18.
Shi, Yanyan, et al.. (2016). Deoxycholic Acid Could Induce Apoptosis and Trigger Gastric Carcinogenesis on Gastric Epithelial Cells by Quantitative Proteomic Analysis. Gastroenterology Research and Practice. 2016. 1–10. 17 indexed citations
19.
Tınay, İlker, Francisco Gelpi‐Hammerschmidt, Jeffrey J. Leow, et al.. (2015). Trends in utilisation, perioperative outcomes, and costs of nephroureterectomies in the management of upper tract urothelial carcinoma: a 10‐year population‐based analysis. British Journal of Urology. 117(6). 954–960. 43 indexed citations
20.
Wang, Ye, et al.. (2015). Regulation of CD4 + T cell subsets on pathogenic mechanism in children with Henoch-Schonlein purpura. Zhonghua shiyong erke linchuang zazhi. 30(21). 1614–1618. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026